The SCN1A mutation database: updating information and analysis of the relationships among genotype, functional alteration, and phenotype - PubMed (original) (raw)
doi: 10.1002/humu.22782. Epub 2015 Apr 13.
Hai-Qing Xu 1, Lu Yu 1, Guo-Wang Lin 1, Na He 1, Tao Su 1, Yi-Wu Shi 1, Bin Li 1, Jie Wang 1, Xiao-Rong Liu 1, Bin Tang 1, Yue-Sheng Long 1, Yong-Hong Yi 1, Wei-Ping Liao 1
Affiliations
- PMID: 25754450
- DOI: 10.1002/humu.22782
The SCN1A mutation database: updating information and analysis of the relationships among genotype, functional alteration, and phenotype
Heng Meng et al. Hum Mutat. 2015 Jun.
Abstract
Mutations in the SCN1A gene have been identified in epilepsy patients with widely variable phenotypes and modes of inheritance and in asymptomatic carriers. This raises challenges in evaluating the pathogenicity of SCN1A mutations. We systematically reviewed all SCN1A mutations and established a database containing information on functional alterations. In total, 1,257 mutations have been identified, of which 81.8% were not recurrent. There was a negative correlation between phenotype severity and missense mutation frequency. Further analyses suggested close relationships among genotype, functional alteration, and phenotype. Missense mutations located in different sodium channel regions were associated with distinct functional changes. Missense mutations in the pore region were characterized by the complete loss of function, similar to haploinsufficiency. Mutations with severe phenotypes were more frequently located in the pore region, suggesting that functional alterations are critical in evaluating pathogenicity and can be applied to patient management. A negative correlation was found between phenotype severity and familial incidence, and incomplete penetrance was associated with missense and splice site mutations, but not truncations or genomic rearrangements, suggesting clinical genetic counseling applications. Mosaic mutations with a load of 12.5-25.0% were potentially pathogenic with low penetrance, suggesting the need for future studies on less pathogenic genomic variations.
Keywords: SCN1A; epilepsy; mosaicism; pathogenicity; sodium channel Nav1.1.
© 2015 WILEY PERIODICALS, INC.
Similar articles
- [Genetic and phenotypic characteristics of SCN1A mutations in Dravet syndrome].
Xu XJ, Zhang YH, Sun HH, Liu XY, Jiang YW, Wu XR. Xu XJ, et al. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2012 Dec;29(6):625-30. doi: 10.3760/cma.j.issn.1003-9406.2012.06.001. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2012. PMID: 23225037 Chinese. - SCN1A testing for epilepsy: application in clinical practice.
Hirose S, Scheffer IE, Marini C, De Jonghe P, Andermann E, Goldman AM, Kauffman M, Tan NC, Lowenstein DH, Sisodiya SM, Ottman R, Berkovic SF; Genetics Commission of the International League Against Epilepsy. Hirose S, et al. Epilepsia. 2013 May;54(5):946-52. doi: 10.1111/epi.12168. Epub 2013 Apr 15. Epilepsia. 2013. PMID: 23586701 - Mosaic SCN1A mutations in familial partial epilepsy with antecedent febrile seizures.
Shi YW, Yu MJ, Long YS, Qin B, He N, Meng H, Liu XR, Deng WY, Gao MM, Yi YH, Li BM, Liao WP. Shi YW, et al. Genes Brain Behav. 2012 Mar;11(2):170-6. doi: 10.1111/j.1601-183X.2011.00756.x. Epub 2011 Dec 14. Genes Brain Behav. 2012. PMID: 22151702 - Ion Channel Genes and Epilepsy: Functional Alteration, Pathogenic Potential, and Mechanism of Epilepsy.
Wei F, Yan LM, Su T, He N, Lin ZJ, Wang J, Shi YW, Yi YH, Liao WP. Wei F, et al. Neurosci Bull. 2017 Aug;33(4):455-477. doi: 10.1007/s12264-017-0134-1. Epub 2017 May 9. Neurosci Bull. 2017. PMID: 28488083 Free PMC article. Review. - SCN1A variants from bench to bedside-improved clinical prediction from functional characterization.
Brunklaus A, Schorge S, Smith AD, Ghanty I, Stewart K, Gardiner S, Du J, Pérez-Palma E, Symonds JD, Collier AC, Lal D, Zuberi SM. Brunklaus A, et al. Hum Mutat. 2020 Feb;41(2):363-374. doi: 10.1002/humu.23943. Epub 2019 Nov 28. Hum Mutat. 2020. PMID: 31782251 Review.
Cited by
- Single-Base Gene Variants in MIR-146A and SCN1A Genes Related to the Epileptogenic Process in Drug-Responsive and Drug-Resistant Temporal Lobe Epilepsy-A Preliminary Study in a Brazilian Cohort Sample.
Buainain RP, Sodré AR, Dos Santos JS, Takazaki KAG, Queiroz LS, de Oliveira CTP, de Aguiar PHP, Marson FAL, Ortega MM. Buainain RP, et al. Int J Mol Sci. 2024 May 30;25(11):6005. doi: 10.3390/ijms25116005. Int J Mol Sci. 2024. PMID: 38892194 Free PMC article. - SCN1A Channels a Wide Range of Epileptic Phenotypes: Report of Novel and Known Variants with Variable Presentations.
Veltra D, Theodorou V, Katsalouli M, Vorgia P, Niotakis G, Tsaprouni T, Pons R, Kosma K, Kampouraki A, Tsoutsou I, Makrythanasis P, Kekou K, Traeger-Synodinos J, Sofocleous C. Veltra D, et al. Int J Mol Sci. 2024 May 22;25(11):5644. doi: 10.3390/ijms25115644. Int J Mol Sci. 2024. PMID: 38891831 Free PMC article. - Efficacy and tolerability of perampanel in pediatric patients with Dravet syndrome.
Muthaffar OY, Bamaga AK, Alyazidi AS, Baaishrah LS, Alkhalifah HA, Hariri RB, Khider MS, Alahmadi SA. Muthaffar OY, et al. Transl Pediatr. 2024 Apr 30;13(4):584-595. doi: 10.21037/tp-23-581. Epub 2024 Apr 18. Transl Pediatr. 2024. PMID: 38715666 Free PMC article. - Unravelling the Genetic Landscape of Hemiplegic Migraine: Exploring Innovative Strategies and Emerging Approaches.
Alfayyadh MM, Maksemous N, Sutherland HG, Lea RA, Griffiths LR. Alfayyadh MM, et al. Genes (Basel). 2024 Mar 31;15(4):443. doi: 10.3390/genes15040443. Genes (Basel). 2024. PMID: 38674378 Free PMC article. Review. - Current state of the epilepsy drug and device pipeline.
Terman SW, Kirkpatrick L, Akiyama LF, Baajour W, Atilgan D, Dorotan MKC, Choi HW, French JA. Terman SW, et al. Epilepsia. 2024 Apr;65(4):833-845. doi: 10.1111/epi.17884. Epub 2024 Feb 12. Epilepsia. 2024. PMID: 38345387 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources